CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn cash
Cash and short-term investments held at the end of each period.
CytoDyn's cash was $16.36M at Aug 31, 2026. For fiscal 2026 it was $11.85M, down 0.4% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is $33.94M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $11.85M | -0.4% |
| FY2025 | May 31, 2025 | $11.90M | +21.3% |
| FY2024 | May 31, 2024 | $9.81M | +8.5% |
| FY2023 | May 31, 2023 | $9.05M | +113.9% |
| FY2022 | May 31, 2022 | $4.23M | -87.5% |
| FY2021 | May 31, 2021 | $33.94M | +137.7% |
| FY2020 | May 31, 2020 | $14.28M | +311.9% |
| FY2019 | May 31, 2019 | $3.47M | +181.6% |
| FY2018 | May 31, 2018 | $1.23M | -30.7% |
| FY2017 | May 31, 2017 | $1.78M | -81.6% |
| FY2016 | May 31, 2016 | $9.64M | +818.2% |
| FY2015 | May 31, 2015 | $1.05M | -78.5% |
| FY2014 | May 31, 2014 | $4.89M | +709.4% |
| FY2013 | May 31, 2013 | $603.68K | +111.8% |
| FY2012 | May 31, 2012 | $284.99K | -72.5% |
| FY2011 | May 31, 2011 | $1.04M | +48.2% |
| FY2010 | May 31, 2010 | $700.50K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $16.36M | +75.3% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $11.85M | -0.4% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $15.66M | -4.5% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $4.98M | -76.6% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $9.33M | -62.6% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $11.90M | +21.3% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | $16.40M | +1068.1% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $21.34M | +14413.6% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $24.92M | +1125.2% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $9.81M | +8.5% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $1.40M | -41.6% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $147.00K | -96.9% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $2.03M | -51.9% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $9.05M | +563.8% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $2.40M | -72.9% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $4.68M | -28.4% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $4.23M | -87.5% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $1.36M | -90.5% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $8.88M | -69.8% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $6.53M | -64.1% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | $33.94M | +137.7% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $14.29M | +102.5% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | $29.41M | +2350.6% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | $18.20M | +913.4% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $14.28M | +311.9% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | $7.06M | +342.8% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | $1.20M | +55.4% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | $1.80M | -62.2% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | $3.47M | +181.6% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | $1.59M | -67.8% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | $772.36K | -40.4% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | $4.75M | +401.9% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | $1.23M | -30.7% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | $4.95M | -36.5% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | $1.30M | -85.3% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | $946.25K | -78.7% |
| Q4 FY2017CQ2 2017 | May 31, 2017 | $1.78M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | $7.80M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | $8.81M | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | $4.44M | – |
See a number that looks wrong?